BLI1100

DRUG2 trials

Sponsors

Braintree Laboratories

Conditions

Acne Vulgaris

Phase 2

BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

CompletedNCT01241331

Braintree LaboratoriesAcne Vulgaris

Start: 2010-11-30Updated: 2012-10-01

BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

CompletedNCT01815450

Braintree LaboratoriesAcne Vulgaris

Start: 2013-02-28Updated: 2015-02-02